Eubulus

China
Jiaxing, Zhejiang, China

Company profile

Eubulus company profile

Eubulus is an early-stage company focusing on building a platform technology for therapeutic enhancement. The company specializes in Proteolysis- targeting chimeras (PROTACSs).

Business identity

Operating status
Active
Company type
For Profit
Founded
2018-01-01, Year

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$10M
Last funding
Series A / $10M / 2021-10-14
Last equity funding
Series A / $10M
Investors
6
Lead investors
2

Founders and investors

Lead investors

Daidai CapitalLong Capital

Investors

Innovation and Technology Venture FundLong CapitalStar CapitalViva BiotechXiamen Changrong Investment Management